This research aims to uncover molecular features associated with metastasis and immune remodeling in uveal melanoma.
Conducted integrated transcriptomic analysis of UVM samples.
Identified molecular markers linked to immune response.
Analyzed data to highlight prognostic indicators.
Identified key molecular features related to UVM metastasis.
Discovered novel prognostic markers for clinical use.
Proposed potential therapeutic targets for treatment.
Abstract
This study identifies critical molecular features underlying UVM metastasis and immune remodeling, providing novel prognostic markers and potential therapeutic targets for clinical management of UVM.